HLA-DOA Antikörper (AA 31-59)
Kurzübersicht für HLA-DOA Antikörper (AA 31-59) (ABIN1839258)
Target
Alle HLA-DOA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 31-59
-
Spezifität
- This HLA-DOA antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 31-59 amino acids from the N-terminal region of human HLA-DOA.
-
Aufreinigung
- Protein A purified
-
-
-
-
Applikationshinweise
- Approved: WB (1:1000)
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Aliquot to avoid repeated freezing and thawing.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Short term 4°C, long term aliquot and store at -20°C, avoid freeze-thaw cycles.
-
-
- HLA-DOA (HLA Class II DO alpha (HLA-DOA))
-
Andere Bezeichnung
- HLA-DOA
-
Hintergrund
-
Name/Gene ID: HLA-DOA
Synonyms: HLA-DOA, HLA-D0-alpha, HLA-DZA, Lymphocyte antigen, MHC class II antigen DOA, MHC DZ alpha, HLA-DNA, HLADZ, MHC DN-alpha -
Gen-ID
- 3111
-
Pathways
- Human Leukocyte Antigen (HLA) in Adaptive Immune Response
Target
-